Object The spontaneous prognostic factors and optimal therapeutic strategy for WHO Grade
II gliomas (GIIGs) have yet to be unanimously defined. Specifically, the role of resection is …

… Van den Bent M, Kros JM, Heimans JJ, et al: Response rate and prognostic factors of recurrent
oligodendroglioma treated with PCV che- … Brada M, Viviers L, Abson C, et al: Phase II …

Most primary central nervous system lymphomas (PCNSLs) in immunocompetent patients
are diffuse large B-cell lymphomas (DLBCLs), characterized by poor prognosis, compared …

Brain tumors have been tested for their glial fibrillary acidic protein (GFAP) content by means
of the rocket electrophoresis technique. Meningiomas and neurinomas were low in GFAP. …

Context: Adrenalectomy is a radical treatment for hypercortisolism in Cushing’s disease.
However, it may lead to Nelson’s syndrome, originally defined by the association of a pituitary …

… Treatment with TMZ could reverse this natural trend, because we found that M-MGMTP
patients had a significantly longer PFS after TMZ than U-MGMTP patients. These results are in …

Patients affected by the multiple endocrine neoplasia type I syndrome (MEN1) display a high
incidence of pituitary adenomas, though it is still unknown whether these pituitary tumors …

… TMZ was administered orally from days 1 through 5 at a starting dose of 200mg/m 2 ,
repeated every 28 days after the first daily dose of TMZ. In the absence of unacceptable toxicity (…

Objective: To investigate possible correlations between tumor location and genetic
alterations in a series of oligodendrogliomas. Methods: A series of 158 consecutive …

A consecutive series of 143 unselected adult patients with histologically proved World Health
Organization grade II gliomas was reviewed to assess the prognostic value of growth rates …